Taiheiyo Cement reviews the progress of the 26 Mid-Term Management Plan and outlines initiatives to achieve ROE of 10%, growth investments in US and Philippines businesses, and plans over 700 billion yen in capital expenditures for sustainable growth.
Erex announced its mid-term management plan for 2027 to 2029, planning to expand its battery storage and aggregation business, strengthen domestic and international biomass power generation, and grow overseas power generation operations.
Sumitomo Pharma forecasts core sales of approximately 260 billion yen, core operating income of approximately 43 billion yen, and free cash flow of approximately 47 billion yen for FY2025, announcing a growth strategy targeting core product sales of 250 billion yen scale in the 2030s.
Denka has formulated Phase 2 of its management plan for fiscal years 2026 to 2028, targeting operating income of 35 billion yen to 45 billion yen and ROE of 6.0% to 8.0%, aiming to balance growth strategies with financial discipline.
Net sales for the fiscal year ended December 2025 were JPY 174.002 billion (up 5.6% Year-over-Year), operating income was JPY 19.722 billion (up 0.4% YoY), and net income attributable to owners of parent was JPY 14.444 billion (down 9.1% YoY).
TOYO TANSO's 2026-2030 Mid-Term Management Plan targets net sales of 74 billion yen, operating income of 18 billion yen, an operating margin of 24%, and ROE of 10%, with plans to strengthen expansion into growth markets and applications alongside capital investments of 37.5 billion yen.
In the fiscal year ending December 2025, eWeLL achieved record-high profits for the seventh consecutive term, maintaining a high-profit structure with an operating income margin of 45%. The commencement of AI service billing in 2026 and plans for revenue growth in the mid-term management plan are also presented.
Formulated a three-year mid-term management plan from the fiscal year ending December 2026 to December 2028. Targeting sales growth from JPY 100.9 billion to JPY 120 billion, and operating income increase from JPY 9.4 billion to JPY 14.4 billion.
In fiscal 2025, sales reached 73,668 million yen, achieving the plan, and operating income of 9,060 million yen was roughly on target. From 2026 to 2028, the company aims to maintain ROE above 10% and PBR above 1.0x, targeting a payout ratio of 45% and establishing a 4 billion yen share buyback program.
Fujibo Holdings has formulated the mid-term management plan 'Evolution 26-30' for fiscal years 2026 to 2030, aiming to achieve consolidated sales of 65 billion JPY and operating income of 13 billion JPY in fiscal 2030.